Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Allucent
Entity

Allucent

Tracked across 1 events · 8 articles · First seen Jun 08, 2026 · Last active Jun 25, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 0
Tech
Quantum BioPharma Advances Lucid-MS to Phase 2
Impact: Allucent entered into a binding letter of intent with Quantum BioPharma to support the execution of the planned phase 2 clinical trial for Lucid-MS.
Jun 08, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Allucent live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.